Intrinsiqq
Immunovant Inc. logo

Immunovant Inc.

IMVT

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$6.57B
EPS-$2.55
P/E-12.46
P/FCF-16.64
EV/EBITDA–
FCF Yield–
Div. Yield–
Net Debt/FCF1.8x
Immunovant Inc. intrinsic value
52-Week Range
$22.02$44.96

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$509M

▼ -22.2% YoY

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF (TTM)

-$395M

▼ -8.1% YoY

Op. Cash Flow (TTM)

-$395M

▼ -8.4% YoY

Net Debt

-$722M

Net Cash Position

Cash & Equiv.

$722M

Continue Research

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with IMVT

CompareIntrinsic value
CELZCreative Medical Technology Holdings Inc.
$0.40-8.14%10
VCELVericel Corporation
$57.52-1.27%65
IOVAIovance Biotherapeutics, Inc.
$6.90-5.61%10
CGONCG Oncology, Inc.
$79.47-2.97%40
TECHBio-Techne Corporation
$72.67-0.04%41
MRNAModerna, Inc.
$195.00-2.17%13
HALOHalozyme Therapeutics Inc.
$91.35-1.82%70
SCLXScilex Holding Company
$0.57-12.95%0

Held by ETFs

IMVT is in 51 US ETFs. The largest of them, with IMVT's weight in each:

Immunovant (IMVT) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-12.46
Negative: a loss over the last twelve months. Price to free cash flow -16.64.
Financials

Questions about Immunovant

Does Immunovant (IMVT) pay a dividend?

No. Immunovant (IMVT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 3 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in IMVT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IMVT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.